TRVI
Trevi Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 6, 2026 3:59:59 PM EST
14.34USD+11.944%(+1.53)2,549,175
TRVI Financials
In Q2 FY 2026 (ended ), Trevi Therapeutics, Inc. Common Stock (TRVI) reported net income of −$17.8M, operating cash flow of −$17.43M, and assets of $330.52M (filed ).
Loading financial flows…